Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autistic Disorder | 25 | 2014 | 167 | 4.170 |
Why?
|
| Autism Spectrum Disorder | 6 | 2023 | 178 | 2.320 |
Why?
|
| Isothiocyanates | 5 | 2021 | 19 | 1.820 |
Why?
|
| Child Development Disorders, Pervasive | 6 | 2015 | 52 | 1.610 |
Why?
|
| Sleep Wake Disorders | 2 | 2023 | 68 | 1.270 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2023 | 166 | 1.210 |
Why?
|
| Child | 27 | 2023 | 4297 | 0.870 |
Why?
|
| Brain | 9 | 2009 | 1487 | 0.690 |
Why?
|
| Child, Preschool | 15 | 2021 | 1836 | 0.660 |
Why?
|
| Prenatal Exposure Delayed Effects | 6 | 2014 | 164 | 0.630 |
Why?
|
| Sleep | 2 | 2023 | 218 | 0.580 |
Why?
|
| Developmental Disabilities | 4 | 2014 | 116 | 0.490 |
Why?
|
| Psychotropic Drugs | 1 | 2016 | 83 | 0.490 |
Why?
|
| Sulfoxides | 4 | 2021 | 20 | 0.480 |
Why?
|
| Nerve Tissue Proteins | 2 | 2008 | 421 | 0.470 |
Why?
|
| Autoantibodies | 4 | 2009 | 174 | 0.460 |
Why?
|
| Cytoprotection | 1 | 2014 | 18 | 0.460 |
Why?
|
| Oxytocin | 1 | 2014 | 49 | 0.440 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2014 | 79 | 0.430 |
Why?
|
| Self-Injurious Behavior | 1 | 2013 | 47 | 0.430 |
Why?
|
| Fever | 2 | 2016 | 63 | 0.420 |
Why?
|
| Fetus | 2 | 2009 | 97 | 0.370 |
Why?
|
| Behavior | 2 | 2008 | 38 | 0.370 |
Why?
|
| Adolescent | 12 | 2016 | 5913 | 0.370 |
Why?
|
| Serotonin | 2 | 2013 | 66 | 0.370 |
Why?
|
| Humans | 37 | 2023 | 59226 | 0.370 |
Why?
|
| Pregnancy | 12 | 2014 | 2352 | 0.350 |
Why?
|
| Receptors, Adrenergic, beta-2 | 3 | 2007 | 10 | 0.350 |
Why?
|
| Immunoglobulin G | 3 | 2009 | 450 | 0.350 |
Why?
|
| Child Behavior | 2 | 2020 | 69 | 0.340 |
Why?
|
| Male | 27 | 2020 | 27470 | 0.340 |
Why?
|
| Case-Control Studies | 8 | 2014 | 1058 | 0.310 |
Why?
|
| Birth Rate | 1 | 2008 | 4 | 0.300 |
Why?
|
| Neuroglia | 2 | 2005 | 79 | 0.300 |
Why?
|
| Fetal Development | 1 | 2008 | 17 | 0.300 |
Why?
|
| Isoantigens | 1 | 2008 | 71 | 0.300 |
Why?
|
| Isoantibodies | 1 | 2008 | 32 | 0.300 |
Why?
|
| Cytokines | 5 | 2020 | 906 | 0.300 |
Why?
|
| Seasons | 1 | 2008 | 129 | 0.290 |
Why?
|
| Central Nervous System Diseases | 1 | 2008 | 56 | 0.290 |
Why?
|
| Female | 25 | 2020 | 30789 | 0.290 |
Why?
|
| Dental Care for Disabled | 1 | 2007 | 3 | 0.280 |
Why?
|
| HLA-DR4 Antigen | 1 | 2006 | 9 | 0.280 |
Why?
|
| Tryptophan | 1 | 2006 | 54 | 0.270 |
Why?
|
| Antibody Formation | 1 | 2006 | 111 | 0.270 |
Why?
|
| Psychoneuroimmunology | 1 | 2005 | 1 | 0.260 |
Why?
|
| Mitochondrial Diseases | 1 | 2006 | 22 | 0.260 |
Why?
|
| Neopterin | 1 | 2005 | 1 | 0.260 |
Why?
|
| Quinolinic Acid | 1 | 2005 | 4 | 0.260 |
Why?
|
| Mental Disorders | 3 | 2012 | 763 | 0.250 |
Why?
|
| Social Behavior | 2 | 2014 | 88 | 0.220 |
Why?
|
| Adult | 11 | 2016 | 15726 | 0.200 |
Why?
|
| Glutamic Acid | 2 | 2007 | 98 | 0.200 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2001 | 31 | 0.190 |
Why?
|
| Triazines | 1 | 2001 | 20 | 0.190 |
Why?
|
| Problem Behavior | 1 | 2020 | 12 | 0.170 |
Why?
|
| Mothers | 3 | 2008 | 261 | 0.170 |
Why?
|
| Prevalence | 1 | 2023 | 1278 | 0.160 |
Why?
|
| Oxygen Consumption | 1 | 2020 | 199 | 0.160 |
Why?
|
| Animals | 8 | 2016 | 19562 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 238 | 0.160 |
Why?
|
| Diagnosis, Differential | 3 | 2012 | 895 | 0.150 |
Why?
|
| Cohort Studies | 3 | 2013 | 2435 | 0.150 |
Why?
|
| Odds Ratio | 4 | 2014 | 772 | 0.140 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2008 | 32 | 0.140 |
Why?
|
| Mitochondria | 1 | 2020 | 333 | 0.140 |
Why?
|
| Terbutaline | 2 | 2007 | 4 | 0.140 |
Why?
|
| Fathers | 2 | 2006 | 26 | 0.140 |
Why?
|
| Siblings | 2 | 2006 | 45 | 0.130 |
Why?
|
| Behavior, Animal | 2 | 2009 | 214 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2009 | 677 | 0.130 |
Why?
|
| Polymorphism, Genetic | 2 | 2007 | 197 | 0.130 |
Why?
|
| Young Adult | 2 | 2016 | 4317 | 0.120 |
Why?
|
| Placebos | 1 | 2014 | 72 | 0.120 |
Why?
|
| Comorbidity | 4 | 2012 | 1084 | 0.110 |
Why?
|
| United States | 3 | 2021 | 7488 | 0.110 |
Why?
|
| Blotting, Western | 4 | 2009 | 594 | 0.100 |
Why?
|
| Language | 1 | 2013 | 140 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 666 | 0.100 |
Why?
|
| Child Behavior Disorders | 1 | 2012 | 42 | 0.100 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2009 | 36 | 0.090 |
Why?
|
| Logistic Models | 2 | 2013 | 1252 | 0.090 |
Why?
|
| Intellectual Disability | 1 | 2013 | 168 | 0.090 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2008 | 35 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 2461 | 0.090 |
Why?
|
| Tocolytic Agents | 2 | 2009 | 5 | 0.090 |
Why?
|
| Adrenergic Agonists | 1 | 2009 | 2 | 0.090 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2009 | 21 | 0.090 |
Why?
|
| Movement Disorders | 1 | 2009 | 23 | 0.080 |
Why?
|
| Gene Frequency | 2 | 2007 | 131 | 0.080 |
Why?
|
| Fetal Proteins | 1 | 2009 | 11 | 0.080 |
Why?
|
| Obstetric Labor, Premature | 2 | 2009 | 33 | 0.080 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2009 | 19 | 0.080 |
Why?
|
| Genotype | 3 | 2007 | 643 | 0.080 |
Why?
|
| Maternal-Fetal Relations | 1 | 2008 | 1 | 0.080 |
Why?
|
| Multiple Birth Offspring | 1 | 2008 | 2 | 0.080 |
Why?
|
| Antibodies, Heterophile | 1 | 2008 | 2 | 0.080 |
Why?
|
| Birth Order | 1 | 2008 | 3 | 0.080 |
Why?
|
| Chemokines | 2 | 2005 | 94 | 0.080 |
Why?
|
| Myelin Basic Protein | 1 | 2008 | 23 | 0.080 |
Why?
|
| Poisson Distribution | 1 | 2008 | 51 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2006 | 453 | 0.080 |
Why?
|
| Sex Factors | 2 | 2014 | 959 | 0.070 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 2007 | 2 | 0.070 |
Why?
|
| Middle Aged | 5 | 2008 | 16227 | 0.070 |
Why?
|
| Parity | 1 | 2008 | 71 | 0.070 |
Why?
|
| Sex Distribution | 1 | 2008 | 254 | 0.070 |
Why?
|
| Species Specificity | 1 | 2008 | 336 | 0.070 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2007 | 29 | 0.070 |
Why?
|
| Cerebral Cortex | 3 | 2005 | 253 | 0.070 |
Why?
|
| Rats | 2 | 2008 | 1907 | 0.070 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2007 | 51 | 0.070 |
Why?
|
| Histocompatibility Testing | 1 | 2006 | 31 | 0.070 |
Why?
|
| Cytochrome-c Oxidase Deficiency | 1 | 2006 | 1 | 0.070 |
Why?
|
| Infant | 3 | 2007 | 1527 | 0.070 |
Why?
|
| Electron Transport Complex III | 1 | 2006 | 5 | 0.070 |
Why?
|
| Aspartate Aminotransferases | 1 | 2006 | 29 | 0.070 |
Why?
|
| Electron Transport Complex I | 1 | 2006 | 16 | 0.070 |
Why?
|
| Creatine Kinase | 1 | 2006 | 42 | 0.070 |
Why?
|
| Pedigree | 1 | 2006 | 190 | 0.060 |
Why?
|
| Risk | 1 | 2007 | 370 | 0.060 |
Why?
|
| Neuroimmunomodulation | 1 | 2005 | 9 | 0.060 |
Why?
|
| Muscular Atrophy | 1 | 2006 | 26 | 0.060 |
Why?
|
| Vaccines | 1 | 2007 | 97 | 0.060 |
Why?
|
| Neurogenic Inflammation | 1 | 2005 | 2 | 0.060 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2005 | 11 | 0.060 |
Why?
|
| Twins, Dizygotic | 1 | 2005 | 54 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 926 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 195 | 0.060 |
Why?
|
| Point Mutation | 1 | 2005 | 162 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2007 | 384 | 0.060 |
Why?
|
| Biopsy | 1 | 2006 | 373 | 0.060 |
Why?
|
| Biomarkers | 2 | 2009 | 1204 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2014 | 5139 | 0.060 |
Why?
|
| Microglia | 1 | 2007 | 227 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2005 | 67 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2007 | 2323 | 0.060 |
Why?
|
| Pregnancy Trimester, First | 2 | 2014 | 29 | 0.060 |
Why?
|
| Pilot Projects | 1 | 2006 | 917 | 0.050 |
Why?
|
| Neurons | 1 | 2008 | 856 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2013 | 5966 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2006 | 1311 | 0.050 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2001 | 14 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 672 | 0.050 |
Why?
|
| Endophenotypes | 1 | 2020 | 8 | 0.040 |
Why?
|
| NADH Dehydrogenase | 1 | 2020 | 5 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2007 | 3094 | 0.040 |
Why?
|
| DNA Copy Number Variations | 1 | 2020 | 65 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2001 | 576 | 0.040 |
Why?
|
| Leukocytes | 1 | 2020 | 107 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2020 | 75 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2001 | 684 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2005 | 1907 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2020 | 185 | 0.040 |
Why?
|
| Twins, Monozygotic | 1 | 1998 | 69 | 0.040 |
Why?
|
| Risk Factors | 2 | 2005 | 4997 | 0.040 |
Why?
|
| Gene Expression | 1 | 2001 | 807 | 0.040 |
Why?
|
| Inflammation | 2 | 2020 | 1100 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 1999 | 222 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 1998 | 217 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 2100 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 846 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2014 | 25 | 0.030 |
Why?
|
| California | 1 | 2014 | 160 | 0.030 |
Why?
|
| Drug Utilization | 1 | 2014 | 223 | 0.030 |
Why?
|
| Aged | 1 | 2008 | 13284 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1992 | 98 | 0.020 |
Why?
|
| Electroencephalography | 1 | 1992 | 136 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 2057 | 0.020 |
Why?
|
| Attention | 1 | 1992 | 153 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2013 | 291 | 0.020 |
Why?
|
| Fetal Distress | 1 | 2009 | 3 | 0.020 |
Why?
|
| Phenotype | 2 | 2007 | 1154 | 0.020 |
Why?
|
| Psychomotor Disorders | 1 | 2009 | 8 | 0.020 |
Why?
|
| Maze Learning | 1 | 2009 | 51 | 0.020 |
Why?
|
| Bronchodilator Agents | 1 | 2009 | 97 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 219 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2013 | 391 | 0.020 |
Why?
|
| Receptors, Oxytocin | 1 | 2007 | 2 | 0.020 |
Why?
|
| Actins | 1 | 2009 | 259 | 0.020 |
Why?
|
| Receptors, Serotonin | 1 | 2007 | 17 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2007 | 32 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 2007 | 35 | 0.020 |
Why?
|
| Reflex, Startle | 1 | 2007 | 6 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2007 | 123 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2007 | 49 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2009 | 519 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2007 | 230 | 0.020 |
Why?
|
| Family Health | 1 | 2007 | 68 | 0.020 |
Why?
|
| Cholesterol | 1 | 2007 | 255 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 569 | 0.020 |
Why?
|
| Asthma | 1 | 2009 | 417 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2007 | 483 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2005 | 21 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 208 | 0.010 |
Why?
|
| Motor Activity | 1 | 2007 | 342 | 0.010 |
Why?
|
| Hypertension | 1 | 2009 | 600 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2007 | 837 | 0.010 |
Why?
|
| Parents | 1 | 2007 | 379 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 3183 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2001 | 80 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2001 | 193 | 0.010 |
Why?
|
| Linear Models | 1 | 2001 | 419 | 0.010 |
Why?
|
| Hyperthyroidism | 1 | 1999 | 17 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2005 | 1290 | 0.010 |
Why?
|
| Caudate Nucleus | 1 | 1998 | 25 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1998 | 44 | 0.010 |
Why?
|
| Health Surveys | 1 | 1999 | 306 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1999 | 156 | 0.010 |
Why?
|
| Cerebellum | 1 | 1998 | 94 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 1998 | 338 | 0.010 |
Why?
|
| Mice | 1 | 2009 | 10237 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1999 | 324 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2001 | 1467 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1999 | 607 | 0.010 |
Why?
|
| Arousal | 1 | 1992 | 42 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1992 | 35 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1992 | 133 | 0.010 |
Why?
|
| Reading | 1 | 1992 | 92 | 0.010 |
Why?
|
| Brain Mapping | 1 | 1992 | 230 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1998 | 2034 | 0.010 |
Why?
|